PML tumour suppression and beyond: therapeutic implications

Area of Science:

• Oncology
• Molecular Biology
• Cellular Biology

Background:

• The Promyelocytic Leukemia protein (PML) is recognized for its tumor-suppressive functions, primarily through its role in PML Nuclear Bodies (PML-NBs).
• PML-NBs act as hubs for cellular stress responses, recruiting and modifying key factors.
• PML also exhibits anti-tumorigenic activities in the cytoplasm.

Purpose of the Study:

• To review the evolving understanding of the Promyelocytic Leukemia protein (PML) in cancer.
• To discuss the paradoxical roles of PML, including its newly identified growth-promoting capabilities.
• To explore the implications of PML's functional diversity for cancer therapy development.

Main Methods:

• Literature review of recent research on PML function in various tumors.
• Analysis of studies investigating PML's role in cellular stress responses and metabolic reprogramming.
• Synthesis of findings regarding PML's dualistic tumor suppressor and promoter activities.

Main Results:

• PML's tumor-suppressive capacity is linked to its function within PML Nuclear Bodies (PML-NBs).
• Recent findings reveal PML can promote tumor cell growth via metabolic reprogramming, challenging its classic tumor suppressor status.
• The diverse functions of PML are likely attributed to its multiple existing forms.

Conclusions:

• The dual role of PML as both a tumor suppressor and promoter presents a significant challenge for targeted cancer therapy.
• Understanding the specific contexts and mechanisms of PML's opposing functions is crucial for developing effective therapeutic strategies.
• This review highlights a paradigm shift in the PML field, emphasizing the need for nuanced approaches to PML-targeted cancer treatments.